Detalhe da pesquisa
1.
Human Herpesvirus-6 Reactivation and Disease Are Infrequent in Chimeric Antigen Receptor T-cell Therapy Recipients.
Blood
; 2024 Apr 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-38635788
2.
Real-World and Clinical Trial Outcomes in Large B-cell Lymphoma with Axicabtagene Ciloleucel Across Race and Ethnicity.
Blood
; 2024 Apr 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-38635762
3.
Outcomes in Hematopoietic Cell Transplant and Chimeric Antigen Receptor T Cell Therapy Recipients with Pre-Cellular Therapy SARS-CoV-2 Infection.
Clin Infect Dis
; 2024 Mar 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38427848
4.
Impact of CD19 CAR T-cell product type on outcomes in relapsed or refractory aggressive B-NHL.
Blood
; 139(26): 3722-3731, 2022 06 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-35439295
5.
γ-Secretase inhibitor in combination with BCMA chimeric antigen receptor T-cell immunotherapy for individuals with relapsed or refractory multiple myeloma: a phase 1, first-in-human trial.
Lancet Oncol
; 24(7): 811-822, 2023 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-37414012
6.
CMV Reactivation and CMV-Specific Cell-Mediated Immunity after Chimeric Antigen Receptor T-Cell Therapy.
Clin Infect Dis
; 2023 Nov 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-37975819
7.
Factors associated with outcomes after a second CD19-targeted CAR T-cell infusion for refractory B-cell malignancies.
Blood
; 137(3): 323-335, 2021 01 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-32967009
8.
Predictors of response to axicabtagene-ciloleucel CAR T cells in aggressive B cell lymphomas: A real-world study.
J Cell Mol Med
; 26(24): 5976-5983, 2022 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-36453136
9.
Feasibility and efficacy of CD19-targeted CAR T cells with concurrent ibrutinib for CLL after ibrutinib failure.
Blood
; 135(19): 1650-1660, 2020 05 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-32076701
10.
High rate of durable complete remission in follicular lymphoma after CD19 CAR-T cell immunotherapy.
Blood
; 134(7): 636-640, 2019 08 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-31648294
11.
Factors associated with durable EFS in adult B-cell ALL patients achieving MRD-negative CR after CD19 CAR T-cell therapy.
Blood
; 133(15): 1652-1663, 2019 04 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-30728140
12.
The response to lymphodepletion impacts PFS in patients with aggressive non-Hodgkin lymphoma treated with CD19 CAR T cells.
Blood
; 133(17): 1876-1887, 2019 04 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-30782611
13.
Acute Lymphoblastic Leukemia, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology.
J Natl Compr Canc Netw
; 19(9): 1079-1109, 2021 09 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-34551384
14.
Efficacy and tolerability of nivolumab after allogeneic transplantation for relapsed Hodgkin lymphoma.
Blood
; 129(18): 2471-2478, 2017 05 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-28270452
15.
Association Between Low Plasma Level of Citrulline Before Allogeneic Hematopoietic Cell Transplantation and Severe Gastrointestinal Graft vs Host Disease.
Clin Gastroenterol Hepatol
; 16(6): 908-917.e2, 2018 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-29258901
16.
Prognostic value of early positron emission tomography in patients with large B-cell lymphoma treated with anti-CD19 chimeric antigen receptor T-cell therapy.
Haematologica
; 108(12): 3433-3437, 2023 Dec 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37259597
17.
Alemtuzumab vs anti-thymocyte globulin in patients transplanted from an unrelated donor after a reduced intensity conditioning.
Eur J Haematol
; 101(4): 466-474, 2018 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-29714032
18.
Development and validation of an automated computational approach to grade immune effector cell-associated hematotoxicity.
Bone Marrow Transplant
; 2024 Apr 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-38627450
19.
Timing of anti-PD-L1 antibody initiation affects efficacy/toxicity of CD19 CAR T-cell therapy for large B-cell lymphoma.
Blood Adv
; 8(2): 453-467, 2024 01 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-37903325
20.
CD19 CAR-T therapy in solid organ transplant recipients: case report and systematic review.
Bone Marrow Transplant
; 58(4): 353-359, 2023 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-36575360